EP3003361
METHODS FOR REDUCING REMNANT CHOLESTEROL AND OTHER LIPOPROTEIN FRACTIONS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
30.5.2014EP published:
3.7.2019EP application number:
14733889.1
EPO information:
European Patent Register
Max expiry date:
29.5.2034
Title:
METHODS FOR REDUCING REMNANT CHOLESTEROL AND OTHER LIPOPROTEIN FRACTIONS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)
Timeline
Today
30.5.2014EP application
3.7.2019EP Publication
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, 10591, Tarrytown, NY, US
Inventor
Name:
SWERGOLD, GaryAddress:
New Rochelle, NY, US
Name:
SASIELA, William, J.Address:
Tarrytown, NY, US
Name:
PORDY, Robert, C.Address:
Tarrytown, NY, US
Priority
Number:
201361828753 PDate:
30.5.2013Country:
US
Number:
201361901705 PDate:
8.11.2013Country:
US
Number:
201361919836 PDate:
23.12.2013Country:
US
Number:
201461935358 PDate:
4.2.2014Country:
US
Number:
201461953959 PDate:
17.3.2014Country:
US
Number:
201461991738 PDate:
12.5.2014Country:
US
Number:
201414290544Date:
29.5.2014Country:
US
Classification
Categories:
A61K 39/00, A61K 39/395, A61P 9/10, C07K 16/40